Returns From New Pharma Policy
|
The new pharma policy ie granting of patents and exclusive marketing rights keeps in mind that a patent lasts for 20 years and a molecule fetches 40 times 4 patents 80 years. The expected return is 3200 times 320,000 per cent for 4 patent molecules for 20 years. Whose sales are just two times the cost of its research.
98803XXXX (Karnataka)
|
(1 votes, average: 4 out of 5)
Loading ...Disclaimer
All the content posted in the 'Business Standard Blogs' section, unless specified otherwise, are made by Business Standard employees. The content posted in 'Business Standard Blogs' does not follow routine internal Business Standard reviews and editorial processes and should be considered only as the views and opinions of the employees and not of Business Standard.
